With the campaign, Highlights REAL, they are spotlighting the everyday experiences of advanced prostate cancer patients and ...
Oric Pharmaceuticals has picked the phase 3 dose for its prostate cancer prospect, barreling into the pivotal program while ...
Where previous research showed that PSMA therapy for prostate cancer can prolong the lives of patients who have exhausted all ...
An ultrasound-based treatment for prostate cancer showed better safety and operative metrics versus robotic radical ...
An exposure-response analysis showed a statistically significant link between higher drug exposure and increased toxicities ...
Prostate cancer affects one in five Australian men, making it the most common cancer in the country. Now, researchers at the ...
This is an opinion column. Remember your name. That admonishment, that warning, or some variation, was often the last thing I ...
The study published by Bastiaan M Privé and colleagues in The Lancet Oncology represents, to our knowledge, the first randomised phase 2 trial evaluating lutetium-177–PSMA-617 (177Lu-PSMA-617) in ...
Women’s HRT patches control prostate cancer as well as standard hormone injections, but with fewer hot flushes and less bone ...
The Prostate Cancer Foundation (PCF) today announced the launch of the Hästens-PCF Global Health Award, a new initiative ...
Sir Chris Hoy reveals prostate cancer diagnosis gave him ‘new purpose’ as he launches mass screening drive - The Olympian ...
This may not apply in your husband’s case, but it’s worth having the conversation. The two meds Goldstein prescribes for men ...